ATG5 and colorectal carcinoma: After adjustment with cell differentiation (moderate + poor vs. well) and/or pathological stage (advanced stage vs. early stage), multiple Cox regression analyses indicated that ATG5 was associated with poor DFS in females (AHR: 3.75, p = 0.004, Table 3), elderly patients (>60) (AHR: 3.18, p = 0.002), poorly differentiated patients (AHR: 1.99, p = 0.010), patients with AJCC pathological stages I + II (AHR: 5.09, p = 0.004), T3 + T4 (AHR: 1.89, p = 0.023) and CRC patients without lymph node invasion (AHR:3.74, p = 0.005) and radiation therapy (AHR: 3.29, p < 0.001).